alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                    EXHIBIT 32.1

                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with Amendment No. 1 to the Quarterly Report on Form 10-Q of
ImClone Systems Incorporated (the "Company") for the period ended September 30,
2003 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, Daniel S. Lynch, Acting Chief Executive Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

          (1) The Report fully complies with the requirements of Section 13(a)
     or 15(d) of the Securities Exchange Act of 1934; and

          (2) The information contained in the Report fairly presents, in all
     material respects, the financial condition and results of operations of the
     Company.

                                                  /s/ DANIEL S. LYNCH
                                          --------------------------------------
                                                     Daniel S. Lynch
                                              Acting Chief Executive Officer

November 13, 2003

     This certification accompanies the Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended.

     A signed original of this written statement required by Section 906 has
been provided to the Company and will be retained by the Company and furnished
to the Securities and Exchange Commission or its staff upon request.
#### § 434.607 Life cycle cost analysis criteria.

607.1 The following life cycle cost criteria applies to the fuel selection requirements of this subpart and to option life cycle cost analyses performed to evaluate energy conservation design alternatives. The fuel source(s) selection shall be made in accordance with the requirements of subpart A of 10 CFR part 436. When performing optional life cycle cost analyses of energy conservation opportunities the designer may use the life cycle cost procedures of subpart A of 10 CFR part 436 or OMB Circular 1-94 or an equivalent procedure that meets the assumptions listed below:

607.1.1 The economic life of the Prototype Building and Proposed Design shall be 25 years. Anticipated replacements or renovations of energy related features and systems in the Prototype or Reference Building and Proposed Design during this period shall be included in their respective life cycle cost calculations.

607.1.2 The designer shall follow established professional cost estimating practices when determining the costs and benefits associated with the energy related features of the Prototype or Reference Building and Proposed Design.

607.1.3 All costs shall be expressed in current dollars. General inflation shall be disregarded. Differential escalation of prices (prices estimated to rise faster or slower than general inflation) for energy used in the life cycle cost calculations shall be those in effect at the time of the latest “Annual Energy Outlook” (DOE/EIA-0383) as published by the Department of Energy's Energy Information Administration.

607.1.4 The economic effects of taxes, depreciation and other factors not consistent with the practices of subpart A of 10 CFR part 436 shall not be included in the life cycle cost calculation.
EXHIBIT
32.1








Certification of Periodic
Financial Report








Pursuant
to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, the undersigned, Andrew E. Kersey, the President and Chief Executive
Officer, and Jeffery A. Baird, the Chief Financial Officer of CAS Medical
Systems, Inc. (the “issuer”), do hereby certify that the report on Form 10-Q
accompanying this certification (the “report”) fully complies with the
requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934
(15 U.S.C. 78m or 78o(d)) and that information contained in the report fairly
presents, in all material respects, the financial condition and results of
operations of the issuer.











/s/
Andrew E. Kersey


Andrew E.
Kersey


President
and Chief Executive Officer


CAS
Medical Systems, Inc.





August
12, 2009














/s/
Jeffery A. Baird


Jeffery
A. Baird


Chief
Financial Officer


CAS
Medical Systems, Inc.





August
12, 2009
**Exhibit 32.1**

**Certification of Chief Executive Officer Under Section 906 of the Sarbanes-Oxley Act of 2002**

 

The undersigned officer of First National Lincoln Corporation (the "Company") hereby certifies that the Company's quarterly report on Form 10-Q for the period ended March 31, 2006 to which this certification is being furnished as an exhibit (the "Report"), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. This certification is provided pursuant to 18 U.S.C. Section 1350 and Item 601(b)(32) of Regulation S-K ("Item 601(b)(32)") promulgated under the Securities Act of 1933, as amended (the "Securities Act"), and the Exchange Act. In accordance with clause (ii) of Item 601(b)(32), thiscertification (A) shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and (B) shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

Date: May 10, 2006

 

/s/ Daniel R. Daigneault

Daniel R. Daigneault

President & Chief Executive Officer

First National Lincoln Corporation
Exhibit 31.1
 CERTIFICATION
  1.
    
    I have reviewed this Quarterly Report on Form 10-Q for the quarter ended January 2,
2010 of Insteel Industries, Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not misleading with respect to the
period covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;4.
    
    The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
     5.
    
    The registrants other certifying officer and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the registrants
auditors and the audit committee of the registrants board of directors (or persons
performing the equivalent functions):
    /s/ H. O. Woltz III

     H. O. Woltz IIIPresident, Chief Executive Officer
and Chairman of the Board
_______________________________________ __ 

### Michigan Supreme Court 

# Order

Lansing, Michigan



## November 25, 2008 Clifford W. Taylor, Chief Justice



## 137154 Michael F. Cavanag h Elizabeth A. Weave r Marilyn Kell y Maura D. Corriga n Robert P. Young, Jr. 

## PEOPLE OF THE STATE OF MICHIGAN, Stephen J. Markman, 

## Plaintiff-Appellee, J ustices



## v SC: 137154 COA: 285611 Kent CC: 07-000473-FH JAMES ORLANDO RAMOS, Defendant-Appellant.

________________ _________________________/

On order of the Court, the ap plication for leave to appeal the July 3, 2008 order of the Court of Appeals is considered, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.

l1117 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

November 25, 2008

Clerk
EXHIBIT
10.31


 


ICU Medical, Inc.
(the “Company”) has entered into an agreement with each of the following
persons, which is substantially identical to the Form of Executive Officer
Retention Agreement filed as Exhibit 10.29 to this Annual Report on Form 10-K.


 


Alison D. Burcar


Richard A.
Costello


Scott E. Lamb


Steven C. Riggs


 


The Company has also
entered into an agreement with George A. Lopez, M.D., which is substantially
identical to the Form of CEO Retention Agreement  filed as Exhibit 10.30 to this Annual
Report on Form 10-K.
#### § 14.21 Filing a claim after an agency final denial.

If, after a final denial by another agency, the claimant files with the NRC a claim arising out of the same incident on which the claim filed with the other agency was based, the submission of the claim to NRC will not toll the requirement of 28 U.S.C. 2401(b) that suit must be filed within six months of the final denial by the other agency, unless the other agency specifically and explicitly treats the submission to NRC as a request for reconsideration under 10 CFR 14.39 and advises the claimant of the action.
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

CRISTOBAL CERVANTES, 

Petitioner-Appellant, 

 v. 

UNITED STATES OF AMERICA, 

Respondent-Appellee.

No. 21-55266 

D.C. No. 5:20-cv-01180-CJC-JC 

MEMORANDUM*

Appeal from the United States District Court

for the Central District of California

Cormac J. Carney, District Judge, Presiding

Submitted March 16, 2022**

Before: SILVERMAN, MILLER, and BUMATAY, Circuit Judges.

Federal prisoner Cristobal Cervantes appeals pro se from the district court’s 

judgment dismissing his 28 U.S.C. § 2241 habeas corpus petition and order 

denying reconsideration. We have jurisdiction under 28 U.S.C. § 1291. We 

review the dismissal of the § 2241 petition de novo, see Alaimalo v. United States,

* This disposition is not appropriate for publication and is not precedent 

except as provided by Ninth Circuit Rule 36-3.

** The panel unanimously concludes this case is suitable for decision 

without oral argument. See Fed. R. App. P. 34(a)(2).

FILED

MAR 25 2022

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 21-55266 

645 F.3d 1042, 1047 (9th Cir. 2011), and the denial of reconsideration for abuse of 

discretion, see Smith v. Clark Cnty. Sch. Dist., 727 F.3d 950, 954 (9th Cir. 2013). 

We affirm.

Cervantes contends that the district court erred by concluding that he could 

not raise his claims challenging his conviction and sentence in a § 2241 petition. 

This court previously denied a certificate of appealability as to those claims. 

Insofar as Cervantes’s opening brief seeks reconsideration of that decision, the 

request is denied. Furthermore, Cervantes waived any challenge to the district 

court’s dismissal of his claims concerning the Bureau of Prisons’ execution of his 

sentence and institutional COVID-19 safety protocols by failing to raise any 

arguments in support of those claims in his opening brief. See Leer v. Murphy, 844 

F.2d 628, 634 (9th Cir. 1988).

Cervantes’s motion for appointment of counsel is denied.

AFFIRMED.
| (logo) WELLS FARGO | **Corporate Trust Services**MAC R1204-0109062 Old Annapolis RoadColumbia, MD 21045Tel: 410 884 2000 Fax: 410 715 2380 |
|--------------------|-----------------------------------------------------------------------------------------------------------------------|

 

 

GS Mortgage Securities Corporation II

200 West Street

New York, New York 10282

 

 

RE: Annual Statement of Compliance for GS Mortgage Securities Corporation II, Commercial Mortgage Pass-Through Certificates, Series 2013-GC10

 

Per the Pooling and Servicing Agreement dated as of February 1, 2013 (the "Agreement"), the undersigned, a duly authorized officer of Wells Fargo Bank, N.A., as Certificate Administrator ("Wells Fargo"), hereby certifies as follows as of and for the year ending December 31, 2015 (the "Reporting Period"):

 

(a) A review of Wells Fargo's activities during the Reporting Period and of its performance under the Agreement has been made under such officer's supervision; and

 

(b) To the best of such officer's knowledge, based on such review, Wells Fargo has fulfilled all of its obligations under the Agreement in all material respects throughout the Reporting Period.

 

 

March 1, 2016

 

/s/ Brian Smith

BRIAN SMITH

Vice President

 

 

Wells Fargo Bank, N.A.
Order entered December 17, 2014

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05
- 14
- 01355
- CR L.D. MILLER, Appellant

V. THE STATE OF TEXAS, Appellee On Appeal from the Criminal District Court No. 7

Dallas County, Texas Trial Court C ause No. F11
- 27250
- Y



### O RDER

T he Court GRANTS court reporter Sharon Hazelwood’s motion for extension of time to file the reporter’s record.
We ORDER Ms. Hazelwood to file the reporter’s record within THIRTY (30) DAYS
from the date of this order

.

/s/ ADA BR OWN JUSTICE
IN THE DISTRICT COURT OF THE UNITED STATES FOR THE

MIDDLE DISTRICT OF ALABAMA, EASTERN DIVISION

OWEN J. ROGAL, D.D.S., )

P.C. d/b/a THE PAIN CENTER, )

)

Plaintiff, )

) CIVIL ACTION NO.

v. ) 3:06cv711-MHT

) 

SKILSTAF, INC., )

)

Defendant. )

ORDER

Because of a scheduling conflict, it is ORDERED that

the uniform scheduling order is amended to reflect that

the pretrial will be on August 8, 2007, with all

deadlines tied to the pretrial date adjusted accordingly.

DONE, this the 21st day of February, 2007.

 /s/ Myron H. Thompson 

UNITED STATES DISTRICT JUDGE

Case 3:06-cv-00711-MHT-WC Document 35 Filed 02/21/2007 Page 1 of 1
Editorial Note on Part 2
Editorial Note: Nomenclature changes to part 2 appear at 79 FR 75739, Dec. 19, 2014.

§ 2.1327 Application for a stay of the effectiveness of NRC staff action on license transfer. ( a ) Any application for a stay of the effectiveness of the NRC staff's order on the license transfer application shall be filed with the Commission within 5 days of the issuance of the notice of staff action pursuant to § 2.1316(a).
( b ) An application for a stay must be no longer than 10 pages, exclusive of affidavits, and must contain: ( 1 ) A concise summary of the action which is requested to be stayed; and
( 2 ) A concise statement of the grounds for a stay, with reference to the factors specified in paragraph (d) of this section.
( c ) Within 10 days after service of an application for a stay under this section, any participant may file an answer supporting or opposing the granting of a stay. Answers must be no longer than 10 pages, exclusive of affidavits, and should concisely address the matters in paragraph (b) of this section, as appropriate. No further replies to answers will be entertained.
( d ) In determining whether to grant or deny an application for a stay, the Commission will consider: ( 1 ) Whether the requestor will be irreparably injured unless a stay is granted;
( 2 ) Whether the requestor has made a strong showing that it is likely to prevail on the merits;
( 3 ) Whether the granting of a stay would harm other participants; and
( 4 ) Where the public interest lies.
PGI 225.001 General.       Consider the following when evaluating offers of foreign end products:          (1) *Statutory or policy restrictions*.          (i) Determine whether the product is restricted by—          (A) Statute (see DFARS Subpart 225.70); or          (B) DoD policy (see DFARS Subpart 225.71,FAR 6.302-3, and DoD Directive 5230.11, Disclosure of Classified Military Information to Foreign Governments and International Organizations).          (ii) If an exception to or waiver of a restriction in DFARS Subpart 225.70 or 225.71 would result in award of a foreign end product, apply the policies and procedures of the Buy American statute or the Balance of Payments Program, and, if applicable, the trade agreements.          (2) *Memoranda of understanding or other international agreements*. Determine whether the offered product is the product of one of the qualifying countries listed in DFARS 225.872-1.          (3) *Trade agreements*. If the product is not an eligible product, a qualifying country end product, or a U.S.-made end product, purchase of the foreign end product may be prohibited (see FAR 25.403(c) and DFARS 225.403(c)).          (4) *Other trade sanctions and prohibited sources*.          (i) Determine whether the offeror complies with the secondary Arab boycott of Israel. Award to such offerors may be prohibited (see DFARS Subpart 225.76).          (ii) Determine whether the offeror is a prohibited source (see FAR Subpart 25.7 and DFARS Subpart 225.7).          (5) *Buy American and Balance of Payments Program*. See the evaluation procedures in DFARS Subpart 225.5.    **Parent topic:** PGI Part 225 - INTERNATIONAL ACQUISITION
Editorial Note on Part 30
Editorial Note: Nomenclature changes to part 30 appear at 79 FR 75739, Dec. 19, 2014.

§ 30.14 Exempt concentrations. ( a ) Except as provided in paragraphs (c) and (d) of this section, any person is exempt from the requirements for a license set forth in section 81 of the Act and from the regulations in this part and parts 31 through 36 and 39 of this chapter to the extent that such person receives, possesses, uses, transfers, owns or acquires products or materials containing byproduct material in concentrations not in excess of those listed in § 30.70.
( b ) This section shall not be deemed to authorize the import of byproduct material or products containing byproduct material.
( c ) A manufacturer, processor, or producer of a product or material is exempt from the requirements for a license set forth in section 81 of the Act and from the regulations in this part and parts 31 through 36 and 39 of this chapter to the extent that this person transfers byproduct material contained in a product or material in concentrations not in excess of those specified in § 30.70 and introduced into the product or material by a licensee holding a specific license issued by the Commission expressly authorizing such introduction. This exemption does not apply to the transfer of byproduct material contained in any food, beverage, cosmetic, drug, or other commodity or product designed for ingestion or inhalation by, or application to, a human being.
( d ) No person may introduce byproduct material into a product or material knowing or having reason to believe that it will be transferred to persons exempt under this section or equivalent regulations of an Agreement State, except in accordance with a license issued under § 32.11 of this chapter.
[30 FR 8185, June 26, 1965, as amended at 40 FR 8785, Mar. 3, 1975; 43 FR 6921, Feb. 17, 1978; 52 FR 8241, Mar. 17, 1987; 58 FR 7736, Feb. 9, 1993; 72 FR 58486, Oct. 16, 2007]
Exhibit 32

          Certification of Chief Executive Officer and Chief Financial
        Officer pursuant to 8 U.S.C. Section 1350 as adopted pursuant to
                 Section 906 of the Sarbanes-Oxley Act of 2002.


                                  CERTIFICATION

In connection with the Quarterly Report of WaterChef, Inc., a Delaware
corporation (the "Company"), on Form 10-Q for the quarter ended June 30, 2004 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), the undersigned, the Chief Executive Officer and Chief Financial
Officer, hereby certifies pursuant to 18 U.S.C. ss.1350 as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge and upon a review
of the Report that:

(1) the Report of the Company filed today pursuant to Section 13(a) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), fully complies
with the requirements of Section 13(a) of the Exchange Act; and

(2) the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

This certification is based upon, among other things, my responsibilities as
Chief Executive Officer, my own due diligence and representations made by
certain members of the Company's senior management.

Dated: December 15, 2004


                                            /s/  David A. Conway
                                            ----------------------------------
                                                 David A. Conway
                                                 President,
                                                 Chief Executive Officer and
                                                 Chief Financial Officer
Exhibit
10.2 Screenplay Assignment for Taken By Storm

    


    SCREENPLAY
ASSIGNMENT

    


    KNOW ALL
MEN BY THESE PRESENTS that, in consideration of one dollar ($1.00) and other
good and valuable consideration, receipt is hereby acknowledged, the undersigned
Wm. Alan Pezzuto (“Assignor”) does hereby sell, grant convey and assign unto
Asgaard Media (“Assignee”), its successors, assigns and licensees forever, all
right title and interest including but not limited to the exclusive world-wide
Motion Picture and allied rights of the Assignor in and to that certain literary
work to wit: that certain original screenplay written by Wm. Alan Pezzuto
entitled “Taken By Storm” hereafter identified as Writers Guild of America, west
(WGAw) Registration number 10000935, which hereto fore may have been written
with the sanction of Assignor.

    


    Dated
This 1st Day of
June, 2008

    


    
      
        
          	
                  /s/Wm.
      Alan Pezzuto

                
	
                  Wm.
      Alan Pezzuto, Assignor

                


        

      

    

     

    AGREED
TO:

    


    
      
        
          	
                  /s/Wm. Alan Pezzuto, On
      behalf of

                
	
                  ASGAARD
      MEDIA

                   Assignee